In December, Zealand Pharma introduced that one a part of the corporate’s utility for dasiglucagon for the remedy of hypoglycemia had been rejected by the US well being authorities.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/zealand-pharma-will-not-seek-compensation-from-contract-manufacturer-after-us-application-issues/
–( COMPANY CABLE)– Atomera Incorporated (Nasdaq: ATOM): THAT: Robert J. Mears, Principal Modern Technology Policeman, Owner of Atomera Incorporated (Nasdaq: ATOM), a se…
STUDY TRIANGULAR PARK, CAROLINE DU NORD–( COMPANY CORD)– Lenovo fête le Cyber Monday avec sa plus grande vente jamais vue! À partir du 1er décembre, les customers de Le…
Canadian mining firm Ivanhoe Mines, which is progressing base steel and platinum team steel jobs in the Autonomous Republic of Congo and South Africa, has actually become part of a…
